Fundz

Exubrion Therapeutics Appoints Jennifer Kirk as Chief Executive Officer

PRIVATEMar 18, 2025

Position

Chief Executive Officer

Company

Exubrion Therapeutics

Jennifer Kirk
BufordBiotechnologyHealth CareTherapeutics

Description

Exubrion Therapeutics announced the appointment of Jennifer Kirk to the company's Board of Directors and as the Chief Executive Officer effective May 3, 2025. Jennifer Kirk brings more than 28 years of leadership and business transformation experience, including a successful tenure at Medtronic, positioning her uniquely to lead Exubrion Therapeutics into the next phase of growth.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Exubrion Therapeutics, and when

A new leader at Exubrion Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Exubrion Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exubrion Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Exubrion Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exubrion Therapeutics

Location

Buford, Georgia, United States

About

Exubrion Therapeutics is the developer of Synovetin OA, a breakthrough injectable treatment that provides long-lasting relief for dogs suffering from chronic osteoarthritis. Utilizing proprietary radiotherapeutic technology, Synovetin OA offers targeted, localized therapy to reduce joint inflammation and pain, often providing up to a full year of improved mobility and quality of life with a single treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exubrion Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Exubrion Therapeutics's next move

Learn about Strategic plan

Exubrion Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.